Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

35.83 +1.69 (+4.95%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,161,988
Open 34.00
Bid (Size) 35.72 (2)
Ask (Size) 35.74 (11)
Prev. Close 34.14
Today's Range 33.73 - 36.47
52wk Range 13.84 - 62.49
Shares Outstanding 40,068,890
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Cassava Sciences Announces Closing of $50 Million Registered Direct Offering
From Cassava Sciences, Inc.
Via Globe NewsWire
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
From Cassava Sciences, Inc.
Via Globe NewsWire

Performance

YTD
-25.26%
-25.26%
1 Month
-0.36%
-0.36%
3 Month
+41.40%
+41.40%
6 Month
+30.01%
+30.01%
1 Year
-26.56%
-26.56%

More News

Read More
7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022
Via InvestorPlace
$100 Invested In Cassava Sciences 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Cassava Sciences: Q3 Earnings Insights
Via Benzinga
Why Is Cassava Sciences (SAVA) Stock Up Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
CASSAVA SCIENCES INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Cassava Sciences, Inc. - SAVA
From Kahn Swick & Foti, LLC
Via Business Wire
Is the Stock Market Open on Election Day 2022?
Via InvestorPlace
Cassava Sciences Has a Big Warning for SAVA Stock Short Sellers
Via InvestorPlace
Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates
From Cassava Sciences, Inc.
Via Globe NewsWire
What the Latest Controversy Really Means for SAVA Stock
Via InvestorPlace
Cassava Sciences Files Lawsuit Against Perpetrators of “Short and Distort” Campaign
From Cassava Sciences, Inc.
Via Globe NewsWire
Why Is Cassava Sciences (SAVA) Stock Down 10% Today?
Via InvestorPlace
A New Study Makes Cassava Sciences Stock an Interesting Buy
Via InvestorPlace
Cassava Sciences Announces Expansion of Leadership Team
From Cassava Sciences, Inc.
Via Globe NewsWire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Short Interest Sector Focus: Healthcare Sector
Via Benzinga
Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients
Via FinancialNewsMedia
CASSAVA SCIENCES INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Cassava Sciences, Inc. - SAVA
From Kahn Swick & Foti, LLC
Via Business Wire
SAVA Stock Alert: Cassava Sciences Extends Trial
Via InvestorPlace
Cassava Sciences Announces Initiation of an Open-label Extension Study
From Cassava Sciences, Inc.
Via Globe NewsWire
Don’t Let Misconduct Allegations Cloud Your Perception of SAVA Stock
Via InvestorPlace
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Via MarketBeat
Exposures Product Safety
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.